1. Home
  2. CMPS vs PRAA Comparison

CMPS vs PRAA Comparison

Compare CMPS & PRAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$6.85

Market Cap

611.6M

Sector

Health Care

ML Signal

HOLD

Logo PRA Group Inc.

PRAA

PRA Group Inc.

HOLD

Current Price

$17.52

Market Cap

536.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPS
PRAA
Founded
2020
1996
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
611.6M
536.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CMPS
PRAA
Price
$6.85
$17.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
3
Target Price
$16.43
$24.33
AVG Volume (30 Days)
1.4M
423.4K
Earning Date
11-04-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,161,679,000.00
Revenue This Year
N/A
$7.85
Revenue Next Year
N/A
$7.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.41
52 Week Low
$2.25
$12.29
52 Week High
$7.15
$23.97

Technical Indicators

Market Signals
Indicator
CMPS
PRAA
Relative Strength Index (RSI) 62.97 59.84
Support Level $6.08 $16.55
Resistance Level $7.15 $18.37
Average True Range (ATR) 0.41 0.67
MACD 0.07 -0.05
Stochastic Oscillator 80.45 55.03

Price Performance

Historical Comparison
CMPS
PRAA

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About PRAA PRA Group Inc.

PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.

Share on Social Networks: